Refine
Year of publication
Document Type
- Article (16)
- Doctoral Thesis (1)
Has Fulltext
- yes (17)
Is part of the Bibliography
- no (17)
Keywords
- dorsal root ganglia (3)
- axon bifurcation (2)
- mice (2)
- neuropathic pain (2)
- pain (2)
- spinal cord (2)
- Adenosine A1 receptor (1)
- Cyclic GMP (1)
- FRET imaging (1)
- Genetic transduction (1)
- Guanylyl cyclases (1)
- In situ hybridization (1)
- Molecular medicine (1)
- NADPH oxidase (1)
- NO (1)
- NO-GC stimulators (1)
- Natriuretic peptides (1)
- Neuropathic pain (1)
- Nitric oxide (1)
- Nox (1)
- Nox inhibition (1)
- Nozizeption (1)
- Npr2 (1)
- P2X3 (1)
- Pain behavior (1)
- Partial agonist (1)
- Patch-clamp (1)
- Phosphodiesterases (1)
- Purkinje cells (1)
- Rab27a (1)
- Rückenmark (1)
- Slack (1)
- Slack channel (1)
- Synaptische Vesikelproteine (1)
- Zentrale Sensibilisierung (1)
- analgesia (1)
- axon branching (1)
- axonal pathfinding (1)
- cGKI (1)
- cGMP (1)
- cGMP signalling (1)
- cerebellar granule cells (1)
- development (1)
- guanylyl cyclase (1)
- hippocampal neurons (1)
- inflammation (1)
- inflammatory pain (1)
- itch (1)
- loxapine (1)
- neuropathy (1)
- nitric oxide (1)
- nociception (1)
- nociception and pain (1)
- peripheral injury (1)
- sensory neurons (1)
- somatosensory system (1)
- striatum (1)
- tolerability and safety (1)
- transgenic mice (1)
Institute
Although the Nobel Prize for the discovery of nitric oxide (NO) dates back almost 20 years now, the knowledge about cGMP signaling is still constantly increasing. It looks even so that our understanding of the role of the soluble guanylyl cyclase (sGC) and particulate guanylyl cyclase (pGC) in health and disease is in many aspects at the beginning and far from being understood. This holds even true for the therapeutic impact of innovative drugs acting on both the NO/sGC and the pGC pathways. Since cGMP, as second messenger, is involved in the pathogenesis of numerous diseases within the cardiovascular, pulmonary, renal, and endocrine systems and also plays a role in neuronal, sensory, and tumor processes, drug applications might be quite broad. On the 8th International Conference on cGMP, held in Bamberg, Germany, world leading experts came together to discuss these topics. All aspects of cGMP research from the basic understanding of cGMP signaling to clinical applicability were discussed in depth. In addition, present and future therapeutic applications of cGMP-modulating pharmacotherapy were presented (http://www.cyclicgmp.net/index.html).